" class="no-js "lang="en-US"> Dominic Raab - Medtech Alert
Wednesday, October 01, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Dominic Raab

Dominic Raab

About Dominic Raab

Dominic Raab is the Secretary of State for Foreign, Commonwealth and Development Affairs and First Secretary of State. Dominic was first appointed Secretary of State for Foreign and Commonwealth Affairs and First Secretary of State on 24 July 2019. He was first elected Conservative MP for Esher and Walton in May 2010.

Related Story

COVID-19

 PHE to Provide Genomic Sequencing Support to Partners Across the World | Pharmtech Focus

PHE to Provide Genomic Sequencing Support to Partners Across the World

July 8 2021

PHE Platform NVAP was announced in January by the Department of Health and Social Care […]